Literature DB >> 8612409

Early prediction of outcome in score-identified, postcardiac surgical patients at high risk for sepsis, using soluble tumor necrosis factor receptor-p55 concentrations.

G Pilz1, P Fraunberger, R Appel, E Kreuzer, K Werdan, A Walli, D Seidel.   

Abstract

OBJECTIVE: To investigate the prognostic value of increased serum concentrations of soluble tumor necrosis factor (TNF) receptors in patients at high risk for sepsis.
DESIGN: Prospective study.
SETTING: Cardiac surgical intensive care unit in a University Hospital. PATIENTS: Those 27 of 870 consecutive postcardiac surgical patients who met a previously validated high-risk criterion for imminent sepsis (Acute Physiology and Chronic Health Evaluation II [APACHE II] score of > or = 24 on the first postoperative day [day 1]). In this population, systemic inflammatory response syndrome was present in 96% of the patients and the in-hospital mortality rate was 30%. In addition, ten postcardiac surgical patients with an uncomplicated course (mortality rate 0%) were studied for comparison.
INTERVENTIONS: Blood sampling for measurements of serum concentrations of TNF and soluble TNF receptors 55 kilodalton (TNF receptor-p55) and 75 kilodalton (TNF receptor-p75) on days 1, 2, 3, and 5.
MEASUREMENTS AND MAIN RESULTS: Compared with the ten patients with an uncomplicated course (group A), the high-risk patients had significantly higher baseline (day 1) serum concentrations of soluble TNF receptor-p55 (9.2 vs. 4.2 ng/mL) and soluble TNF receptor-p75 (9.2 vs. 5.5 ng/mL). These high-risk patients could be further differentiated into two subgroups: one (B) with a prompt decrease in APACHE II score and a good prognosis (mortality rate 0%) and another (C) with a persisting high risk of sepsis and mortality rate (40%, p < .05). Although baseline APACHE II score was similar in both high-risk subgroups, soluble TNF receptor-p55 concentrations were significantly higher in subgroup C compared with subgroup B already at baseline (10.7 vs. 4.7 ng/mL). The receiver operating characteristic curve for subgroup classification by soluble TNF receptor-p55 was in a discriminating position with an area (0.773 +/- 0.096), confirming soluble TNF receptor-p55 as a predictor of mortality. TNF and soluble TNF receptor-p75 concentrations were less predictive at baseline.
CONCLUSIONS: This study suggest that increased soluble TNF receptor-p55 concentrations in the serum of postcardiac surgical patients allow earlier prognostication of subsequent hospital course than APACHE II scores alone. This study further suggests that the combination of physiologic scores and cytokine receptor measurements could improve the predictive power of early postoperative risk stratification.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8612409     DOI: 10.1097/00003246-199604000-00008

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  5 in total

1.  Developing predictive models using electronic medical records: challenges and pitfalls.

Authors:  Chris Paxton; Alexandru Niculescu-Mizil; Suchi Saria
Journal:  AMIA Annu Symp Proc       Date:  2013-11-16

Review 2.  [The importance of cytokines in the posttraumatic inflammatory reaction].

Authors:  F Hildebrand; H-C Pape; C Krettek
Journal:  Unfallchirurg       Date:  2005-10       Impact factor: 1.000

3.  Association Between Serum Tumor Necrosis Factor Receptor 1 and Trajectories of Functional Status: The Northern Manhattan Study.

Authors:  Mandip S Dhamoon; Ying-Kuen Cheung; Yeseon P Moon; Clinton B Wright; Joshua Z Willey; Ralph L Sacco; Mitchell S V Elkind
Journal:  Am J Epidemiol       Date:  2017-07-01       Impact factor: 4.897

Review 4.  Elucidating molecular mechanisms of septic cardiomyopathy--the cardiomyocyte model.

Authors:  K Werdan; U Müller-Werdan
Journal:  Mol Cell Biochem       Date:  1996 Oct-Nov       Impact factor: 3.842

5.  Tumour necrosis factor receptor 1 and mortality in a multi-ethnic cohort: the Northern Manhattan Study.

Authors:  Jorge M Luna; Yeseon Moon; Khin Liu; Steven Spitalnik; Myunghee Paik; Ralph Sacco; Mitchell S V Elkind
Journal:  Age Ageing       Date:  2013-01-15       Impact factor: 10.668

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.